<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00846950</url>
  </required_header>
  <id_info>
    <org_study_id>06-3-075</org_study_id>
    <nct_id>NCT00846950</nct_id>
  </id_info>
  <brief_title>Effects of H1-Antagonist on Cognition</brief_title>
  <official_title>Effects of H1-Antagonist on Stages of Human Information Processing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether histamine is involved in memory and
      specific processes in human cognition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The neurotransmitter histamine appears to be involved in human cognitive performance.
      However, the exact role is very unclear. The role it plays in memory performance is highly
      disputed, as animal studies show decreased performance when the H1-receptor is blocked in the
      central nervous system while such findings in humans is scarce. To clarify the role of
      histamine in human memory and different processes in cognition, the effects of an
      H1-antagonist (dexchlorpheniramine) on memory, alertness and sensory and motor processes are
      measured. The study will be conducted according to a within subject cross-over design using
      healthy volunteers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>P300 latency and LRP onset latency</measure>
    <time_frame>1.5 hours after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Words recalled</measure>
    <time_frame>1.5 hours after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Cognition</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexchlorpheniramine, lorazepam</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy as determined by a physician

        Exclusion Criteria:

          -  present or history of any neurological of psychiatric disease

          -  present or history of any substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annemiek Vermeeren, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Psychology and Neuroscience, Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229 ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.epu-um.nl</url>
    <description>webpage of the experimental psychopharmacology unit of the Maastricht University</description>
  </link>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2009</study_first_submitted>
  <study_first_submitted_qc>February 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2009</study_first_posted>
  <last_update_submitted>February 18, 2009</last_update_submitted>
  <last_update_submitted_qc>February 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2009</last_update_posted>
  <responsible_party>
    <name_title>Effects of H1-antagonist on stages of human information processing</name_title>
    <organization>Dr. A. Vermeeren</organization>
  </responsible_party>
  <keyword>H1-antagonist</keyword>
  <keyword>Event Related Potentials</keyword>
  <keyword>Memory</keyword>
  <keyword>Information processing</keyword>
  <keyword>The effects of an H1 antagonist (dexchlorpheniramine) on human cognition</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Dexchlorpheniramine</mesh_term>
    <mesh_term>Chlorpheniramine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

